Protecting the Entire Data & Insight Pipeline
Instead of relying on narrow technical claims, Nuvo’s IP strategy creates durable barriers to entry by protecting how data is captured, processed, and transformed into clinical value.
Data Acquisition & Sensors
Protecting the hardware designs, sensor placements, and wearable configurations that enable consistent, high-quality signal capture across different body types and gestational ages.
Signal Separation & Quality
Proprietary methods for separating fetal heart signals from maternal noise and motion artifacts, ensuring clinical-grade data integrity in real-world environments.
AI & Clinical Interpretation
Protecting the advanced algorithms and AI models that transform raw ECG and PCG data into actionable clinical assessments for fetal and maternal well-being.
More Than the Sum of Its Parts
Nuvo is a pioneer in jointly analyzing multiple biophysical signals at scale. Our patents protect the fusion of electrical (ECG) and acoustic (PCG) data, allowing the system to compensate for motion and provide a coherent, validated view of pregnancy that single-signal technologies cannot replicate.
A Self-Reinforcing Advantage
Because our platform enables continuous monitoring in real-world settings, it generates a growing repository of high-quality, longitudinal data. This data strengthens our AI models, which in turn improves clinical performance and reinforces adoption—a flywheel effect protected by our core IP.
Strategic Value Beyond the Product
Our IP strategy isn’t just about protecting features; it’s about creating long-term strategic value. This supports competitive defense, partnership leverage for global collaborations, and clear ownership over an entirely new category of maternal health data.